Dr. Susan Goodman is a Rheumatologist at HSS. She specializes in treatment of patients with inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis, and spondylarthritis. Her other areas of specialization is in the perioperative care of patients with rheumatic diseases.
Research interests have focused on the perioperative outcomes of rheumatic disease patients undergoing arthroplasty.
Attending Physician, Hospital for Special Surgery
Associate Professor of Medicine, Weill Cornell Medical College
Soft Tissue Injections
Blue Cross Blue Shield PPO HMO POS
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of April 21, 2015, Dr. Goodman reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
American Board of Internal Medicine, 1980
American Board of Internal Medicine/Rheumatology, 1982
Goodman SM. Rheumatoid arthritis: preoperative evaluation for total hip and total knee replacement surgery. J Clin Rheumatol 2013; Jun;19(4):187-92.
Goodman SM. Invited commentary. Sacroiliitis associated with axial spondyloarthropathy: new concepts and the latest trends. Radiographics 2013; Jul-Aug;33(4):956,8; discussion 959-61.
Goodman SM, Mackenzie CR. Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery. Curr Rheumatol Rep 2013; Sep;15(9):354,013-0354-y.
Johnson BK, Goodman SM, Alexiades MM, Figgie MP, Demmer RT, Mandl LA. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J Rheumatol 2013; May;40(5):617-23.
Stundner O, Chiu YL, Sun X, Goodman SM, Russell LA, Calloway JJ, et al. Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study. Clin Exp Rheumatol 2013; Nov 14
Stundner O, Danninger T, Chiu YL, Sun X, Goodman SM, Russell LA, et al. Rheumatoid Arthritis vs Osteoarthritis in Patients Receiving Total Knee Arthroplasty: Perioperative Outcomes. J Arthroplasty 2013; Jun 11;.
Kim SS, Perino G, Boettner F, Miller A, Goodman S. Salmonella septic arthritis of the knees in a patient with systemic lupus erythematosus. Lupus 2013; Jun;22(7):740-3.
Goodman SM, Perez-Aso M, Cronstein B. Wound Healing and Anti-Rheumatic Agents. ACR Drug Safety Quarterly 2013; vol 4 (3)
Goodman SM, Mandl LA, Johnson B, Huang W-, Figgie MP, Alexiades M, Ghomrawi H. The Use of Biologic DMARDS Identifies Rheumatoid Arthritis Patients with More Optimistic Expectations of Total Knee Arthroplasty HSSJ in press
For more publications, please see the PubMed listing.
perioperative outcomes of rheumatic disease patients undergoing arthroplasty